glp-1 agonists weight loss side effects GLP-1RA Essentials in Gastroenterology: Effect Management, Precautions for Endoscopy and Applications for Gastrointestinal Disease Treatment π GLP-1 Weight Loss Medications
Description
Meyer RK, Duca FA
& Nomura, Y

Novo holds a commanding position in the GLP-1 market, with nearly two-thirds of patients using its treatments, supported by robust sales growth and a positive market outlook
Mechanism of Action Analysis Peripherally acting anti-obesity drugs have become a significant segment in the global anti-obesity market holding 58.5% share in 2024, primarily due to their targeted mechanisms and favorable safety profiles

3), which provides a graphical representation of the risk of bias across studies and criteria [10]
